Catella AB Series B
Catella AB (publ) is a real estate investment firm. The firm together with its subsidiaries, provides property advisory and investments, and fund management services in Europe. The company operates in two segments, Corporate Finance and Asset Management. The Corporate Finance segment offers strategic advisory, capital market-related, and transaction advisory services to real estate companies, fin… Read more
Catella AB Series B (0RL4) - Net Assets
Latest net assets as of December 2025: Skr1.93 Billion SEK
Based on the latest financial reports, Catella AB Series B (0RL4) has net assets worth Skr1.93 Billion SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr4.14 Billion) and total liabilities (Skr2.22 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr1.93 Billion |
| % of Total Assets | 46.53% |
| Annual Growth Rate | 3.09% |
| 5-Year Change | 5.93% |
| 10-Year Change | 11.45% |
| Growth Volatility | 22.65 |
Catella AB Series B - Net Assets Trend (2002–2025)
This chart illustrates how Catella AB Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Catella AB Series B (2002–2025)
The table below shows the annual net assets of Catella AB Series B from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.93 Billion | -5.44% |
| 2024-12-31 | Skr2.04 Billion | +0.05% |
| 2023-12-31 | Skr2.04 Billion | -16.13% |
| 2022-12-31 | Skr2.43 Billion | +33.52% |
| 2021-12-31 | Skr1.82 Billion | +1.28% |
| 2020-12-31 | Skr1.80 Billion | +3.51% |
| 2019-12-31 | Skr1.74 Billion | +5.40% |
| 2018-12-31 | Skr1.65 Billion | -15.23% |
| 2017-12-31 | Skr1.94 Billion | +12.31% |
| 2016-12-31 | Skr1.73 Billion | +20.47% |
| 2015-12-31 | Skr1.44 Billion | +14.70% |
| 2014-12-31 | Skr1.25 Billion | +34.33% |
| 2013-12-31 | Skr932.00 Million | +0.76% |
| 2012-12-31 | Skr925.00 Million | -5.61% |
| 2011-12-31 | Skr980.00 Million | -3.16% |
| 2010-12-31 | Skr1.01 Billion | -3.71% |
| 2009-12-31 | Skr1.05 Billion | +87.01% |
| 2008-12-31 | Skr562.00 Million | -0.88% |
| 2007-12-31 | Skr567.00 Million | -23.89% |
| 2006-12-31 | Skr745.00 Million | -21.25% |
| 2005-12-31 | Skr946.00 Million | +0.53% |
| 2004-12-31 | Skr941.00 Million | +6.33% |
| 2003-12-31 | Skr885.00 Million | -7.62% |
| 2002-12-31 | Skr958.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Catella AB Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 141900000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr1.39 Billion | 73.29% |
| Common Stock | Skr177.00 Million | 9.36% |
| Other Comprehensive Income | Skr32.00 Million | 1.69% |
| Other Components | Skr296.00 Million | 15.65% |
| Total Equity | Skr1.89 Billion | 100.00% |
Catella AB Series B Competitors by Market Cap
The table below lists competitors of Catella AB Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Agencia Comercial Spirits Ltd Class A Ordinary Shares
NASDAQ:AGCC
|
$74.90 Million |
|
Creepy Jar SA
WAR:CRJ
|
$74.92 Million |
|
Cingulate Inc
NASDAQ:CING
|
$74.93 Million |
|
Exotic Food Public Company Limited
BK:XO
|
$74.93 Million |
|
Union Medical Healthcare Limited
PINK:UNHLF
|
$74.82 Million |
|
Ujaas Energy Limited
NSE:UEL
|
$74.81 Million |
|
We&Win Diversification Co Ltd
TWO:4113
|
$74.80 Million |
|
Centaurus Metals Limited
OTCQX:CTTZF
|
$74.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Catella AB Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,997,000,000 to 1,891,000,000, a change of -106,000,000 (-5.3%).
- Net income of 48,000,000 contributed positively to equity growth.
- Dividend payments of 80,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 89,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr48.00 Million | +2.54% |
| Dividends Paid | Skr80.00 Million | -4.23% |
| Other Comprehensive Income | Skr-89.00 Million | -4.71% |
| Other Changes | Skr15.00 Million | +0.79% |
| Total Change | Skr- | -5.31% |
Book Value vs Market Value Analysis
This analysis compares Catella AB Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.16x to 1.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | Skr18.72 | Skr21.63 | x |
| 2003-12-31 | Skr17.11 | Skr21.63 | x |
| 2004-12-31 | Skr18.33 | Skr21.63 | x |
| 2005-12-31 | Skr18.53 | Skr21.63 | x |
| 2006-12-31 | Skr13.57 | Skr21.63 | x |
| 2007-12-31 | Skr6.94 | Skr21.63 | x |
| 2008-12-31 | Skr6.88 | Skr21.63 | x |
| 2009-12-31 | Skr12.55 | Skr21.63 | x |
| 2010-12-31 | Skr11.15 | Skr21.63 | x |
| 2011-12-31 | Skr9.94 | Skr21.63 | x |
| 2012-12-31 | Skr11.07 | Skr21.63 | x |
| 2013-12-31 | Skr11.07 | Skr21.63 | x |
| 2014-12-31 | Skr14.25 | Skr21.63 | x |
| 2015-12-31 | Skr14.31 | Skr21.63 | x |
| 2016-12-31 | Skr17.61 | Skr21.63 | x |
| 2017-12-31 | Skr19.50 | Skr21.63 | x |
| 2018-12-31 | Skr17.14 | Skr21.63 | x |
| 2019-12-31 | Skr17.25 | Skr21.63 | x |
| 2020-12-31 | Skr18.24 | Skr21.63 | x |
| 2021-12-31 | Skr18.63 | Skr21.63 | x |
| 2022-12-31 | Skr23.91 | Skr21.63 | x |
| 2023-12-31 | Skr22.55 | Skr21.63 | x |
| 2024-12-31 | Skr22.60 | Skr21.63 | x |
| 2025-12-31 | Skr21.40 | Skr21.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Catella AB Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.32%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 2.19x
- Recent ROE (2.54%) is below the historical average (3.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -3.45% | -0.26% | 3.26x | 4.10x | Skr-128.60 Million |
| 2003 | 0.11% | 0.01% | 3.16x | 4.24x | Skr-87.30 Million |
| 2004 | 6.38% | 0.50% | 3.19x | 4.00x | Skr-34.10 Million |
| 2005 | -2.01% | -0.20% | 2.16x | 4.56x | Skr-113.60 Million |
| 2006 | -40.81% | -3.37% | 2.64x | 4.58x | Skr-378.50 Million |
| 2007 | -31.92% | -2.24% | 2.89x | 4.92x | Skr-237.70 Million |
| 2008 | 1.78% | 0.37% | 4.17x | 1.14x | Skr-46.20 Million |
| 2009 | 46.05% | 217.51% | 0.05x | 3.86x | Skr369.50 Million |
| 2010 | 2.56% | 4.27% | 0.11x | 5.47x | Skr-72.60 Million |
| 2011 | 2.11% | 1.91% | 0.27x | 4.12x | Skr-74.90 Million |
| 2012 | -1.55% | -1.44% | 0.28x | 3.83x | Skr-104.40 Million |
| 2013 | -2.43% | -2.16% | 0.29x | 3.85x | Skr-112.40 Million |
| 2014 | 18.64% | 15.02% | 0.33x | 3.74x | Skr100.60 Million |
| 2015 | 18.42% | 13.12% | 0.37x | 3.80x | Skr111.10 Million |
| 2016 | 17.40% | 13.55% | 0.36x | 3.62x | Skr115.70 Million |
| 2017 | 11.10% | 9.60% | 0.31x | 3.70x | Skr19.10 Million |
| 2018 | -7.77% | -5.19% | 0.31x | 4.86x | Skr-256.20 Million |
| 2019 | 7.42% | 4.80% | 0.58x | 2.67x | Skr-39.20 Million |
| 2020 | 4.03% | 3.17% | 0.48x | 2.63x | Skr-96.20 Million |
| 2021 | 10.31% | 10.03% | 0.32x | 3.22x | Skr5.20 Million |
| 2022 | 22.65% | 19.57% | 0.40x | 2.92x | Skr274.20 Million |
| 2023 | -1.06% | -1.04% | 0.37x | 2.74x | Skr-219.80 Million |
| 2024 | 1.50% | 1.36% | 0.40x | 2.78x | Skr-169.70 Million |
| 2025 | 2.54% | 2.32% | 0.50x | 2.19x | Skr-141.10 Million |
Industry Comparison
This section compares Catella AB Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Catella AB Series B (0RL4) | Skr1.93 Billion | -3.45% | 1.15x | $74.85 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |